» Articles » PMID: 11912263

Use of the Albumin/creatinine Ratio to Detect Microalbuminuria: Implications of Sex and Race

Overview
Specialty Nephrology
Date 2002 Mar 26
PMID 11912263
Citations 144
Authors
Affiliations
Soon will be listed here.
Abstract

The recommended albumin (microg)/creatinine (mg) ratio (ACR) (30 microg/mg) to detect microalbuminuria does not account for sex or racial differences in creatinine excretion. In a nationally representative sample of subjects, the distribution of urine albumin and creatinine concentrations was examined by using one ACR value (> or =30 microg/mg) and sex-specific cutpoints (> or =17 microg/mg in men and > or =25 microg/mg in women) measured in spot urine specimens. Mean urine albumin concentrations were not significantly different between men and women, but urine creatinine concentrations were significantly higher (P < 0.0001). Compared with non-Hispanic whites, urine creatinine concentrations were significantly higher in non-Hispanic blacks (NHB) and Mexican Americans, whereas urine albumin concentrations were significantly higher in NHB (P < 0.0001) but not Mexican Americans. When a single ACR is used, the prevalence of microalbuminuria was significantly lower among the men compared with women (6.0 versus 9.2%; P < 0.0001) and among non-Hispanic whites compared with NHB (7.2 versus 10.2%; P < 0.0001). No significant difference in the prevalence of microalbuminuria between men and women was noted when sex-specific ACR cutpoints were used. In the multivariate adjusted model, female sex (odds ratio, 1.62; 95% confidence interval, 1.29 to 2.05) and NHB race/ethnicity (odds ratio, 1.34; 95% confidence interval, 1.12 to 1.61) were independently associated with microalbuminuria when a single ACR threshold was used. When a sex-specific ACR was used, NHB race/ethnicity remained significantly associated with microalbuminuria but sex did not. The use of one ACR value to define microalbuminuria may underestimate microalbuminuria in subjects with higher muscle mass (men) and possibly members of certain racial/ethnic groups.

Citing Articles

Using Risk Assessment to Improve Screening for Albuminuria among US Adults without Diabetes.

Bragg-Gresham J, Annadanam S, Gillespie B, Li Y, Powe N, Saran R J Gen Intern Med. 2024; .

PMID: 39557751 DOI: 10.1007/s11606-024-09185-9.


Urinary CXCL-10, a prognostic biomarker for kidney graft injuries: a systematic review and meta-analysis.

Janfeshan S, Afshari A, Yaghobi R, Roozbeh J BMC Nephrol. 2024; 25(1):292.

PMID: 39232662 PMC: 11375915. DOI: 10.1186/s12882-024-03728-2.


Urinary-based detection of MSL, HE4 and CA125 as an additional dimension for predictive and prognostic modelling in ovarian cancer.

Schwarz F, Klotz D, Wimberger P, Kuhlmann J Front Oncol. 2024; 14:1392545.

PMID: 39077473 PMC: 11284093. DOI: 10.3389/fonc.2024.1392545.


Handheld Biosensor System Based on a Gradient Grating Period Guided-Mode Resonance Device.

Chiang C, Tseng W, Tsai W, Huang C Biosensors (Basel). 2024; 14(1).

PMID: 38248398 PMC: 10813047. DOI: 10.3390/bios14010021.


Association of urinary albumin-to-creatinine ratio with cardiometabolic risk markers and pre-diabetes in adults with normoglycemia, normoalbuminuria, and normotension with parental type 2 diabetes.

Everett M, Rushing N, Asuzu P, Wan J, Dagogo-Jack S BMJ Open Diabetes Res Care. 2024; 12(1).

PMID: 38233076 PMC: 10806903. DOI: 10.1136/bmjdrc-2023-003609.